Philip Bardin leads the Respiratory and Lung Research Group, is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing and Health Sciences, Monash University and Director of Monash Respiratory and Sleep Medicine at Monash Medical Centre in Clayton, Melbourne. Prof Bardin is recognised for research into virus-asthma exacerbations and has conducted extensive research in clinical asthma therapies and treatment. Recently, his research group pioneered investigations of vocal cord dysfunction in asthma.
Prof Bardin is a Respiratory Physician (FRACP) and also obtained a PhD at Southampton University, working under Stephen Holgate. He has received Australian NHMRC funding and other research grants and has published widely in respiratory medicine. A network of collaborations in Australia, North America and Europe are ongoing.
Currently, Prof Bardin is co-editor of Respirology, the official journal of The Thoracic Society of Australia and New Zealand (TSANZ) and the Asian Pacific Society of Respirology (APSR). He has chaired the TSANZ Asthma and Allergy Special Interest Group, served on Australian NHMRC Grant Review Panels (Respiratory and Sleep Medicine) and chaired the NHMRC Respiratory and Sleep Medicine Grant Review Panel. Recently he served on the Australian NHMRC Academy.
Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Hew M, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Rivero AL, Marks GB, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PA, Yang IA, Yap E, Gibson PG (2018) Working while unwell: Workplace impairment in people with severe asthma. Clin Exp Allergy Apr 20. doi: 10.1111/cea.1315
Bardin PG (2018) Escalating Inhaled Glucocorticoids to Prevent Asthma Exacerbations. N Engl J Med 378(10):950- 952.
Robertson J, Nicholls S, Bardin P, Ptasznik R, Steinfort D, Miller A (2017) Incidental Pulmonary Nodules Are Common on CT Coronary Angiogram and Have a Significant Cost Impact. Heart Lung Circ pii: S1443-9506(17)31497-X.
Osadnik CR, MacDonald Ml, Bardin PG (2017) The effect of smoking on exacerbation risk in eosinophilic patients with COPD. Eur Respir J 50(6). pii: 1701820.
Sharma R, O’Sullivan KM, Holdsworth SR, Bardin PG, King PT (2017) Visualizing Macrophage Extracellular Traps Using Confocal Microscopy. J Vis Exp (128) doi: 10.3791/56459.
King PT, Sharma R, O’Sullivan KM, Callaghan J, Dousha L, Thomas B, Ruwanpura S, Lim S, Farmer MW, Jennings BR, Finsterbusch M, Brooks G, Selemidis S, Anderson GP, Holdsworth SR, Bardin PG (2017) Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung. Sci Rep 7(1):12128.
Law N, Ruane LE, Low K, Hamza K, Bardin PG (2018) Dysfunctional breathing is more frequent in chronic obstructive pulmonary disease than in asthma and in health. Respir Physiol Neurobiol 247:20-23.
Leong P, Tran A, Rangaswamy J, Ruane LE, Fernando MW, MacDonald Ml, Lau KK, Bardin PG (2017) Expiratory central airway collapse in stable COPD and during exacerbations. Respir Res 18(1):163.
Bardin PG, Low K, Ruane L, Lau KK (2017) Controversies and conundrums in vocal cord dysfunction. Lancet Respir Med 5(7):546-548.
Bardin PG, Price D, Chanez P, Humbert M, Bourdin A (2017) Managing asthma in the era of biological therapies. Lancet Respir Med 5(5):376-378.
Kan-0 K, Ramirez R, MacDonald Ml, Rolph M, Rudd PA, Spann KM, Mahalingam S, Bardin PG, Thomas BJ (2017) Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon. J Infect Dis 215(10):1536-1545.
Thomas BJ, Kan-0 K, Loveland KL, Elias JA, Bardin PG (2016) In the Shadow of Fibrosis: Innate Immune Suppression Mediated by Transforming Growth Factor. Am J Respir Cell Mol Biol 55(6):759-766.